Provider
Interleukin-1 (IL-1) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Aug 01, 2024
Prior Authorization, Quantity Limit
Program effective Date: Aug 01, 2024
Program effective Date: Nov 10, 2021
Program effective Date: Nov 24, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 10, 2021